This report analyzes the worldwide markets for Molecular Diagnostics in Millions of US$.
The specific product segments analyzed are Infectious Disease Testing, Pharmacogenomics, and Cancer Screening.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual forecasts are provided for each region and product segment for the period of 2000 through 2010.
The report profiles 103 companies including many key and niche players worldwide such as Abbott Laboratories, Vysis, Inc., Applera Corporation, Celera Diagnostics, Biomérieux, Digene Corporation, GE Healthcare, Gen-Probe Inc., Genzyme Corporation, Genzyme Genetics, MiraiBio, Inc., Molecular Diagnostics Inc., Nanogen, Novartis Vaccines & Diagnostics, Inc., QIAGEN N.
V, Quest Diagnostics Incorporated, Roche Diagnostics, Siemens Medical Solutions Diagnostics, and Tecan Group Ltd.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.